Joshua D Katz MD

Neuroimmunology/Multiple Sclerosis

Assistant Professor, Neurology, Tufts Medical Center

110 Cedar StSte 110Wellesley, MA 02481
Phone+1 781-591-8300
Fax+1 781-591-8320

Dr. Katz is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Katz's full profile Already have an account?

Education & Training

Tufts Medical CenterResidency, Neurology, 1995 - 1998
Mass General Brigham/Brigham and Women's Hospital/Harvard Medical SchoolResidency, Psychiatry, 1993 - 1995
St Elizabeth's Medical CenterInternship, Internal Medicine, 1992 - 1993
Tufts University School of MedicineClass of 1992

The following disclaimer is related to board certifications obtained from ABMS®, denoted by the ABMS® logo.

This information is proprietary data maintained in a copyrighted database owned by the American Board of Medical Specialties®. The display and presence of ABMS Data in no way constitutes any affiliation, association with, or endorsement of any advertising, promotion, or sponsorship by ABMS and its affiliates and subsidiaries, the ABMS Member Boards, or ABMS board certified physicians and medical specialists. Copyright 2026 American Board of Medical Specialties®. All rights reserved.

The user is responsible for ensuring that the profile obtained in this directory is the profile of the physician or medical specialist being sought.

A self-designated specialty, subspecialty, or practice area neither implies nor is equivalent to ABMS board certification or the existence of specialized training by or competence of a physician or medical specialist.

Certifications & Licensure

MA State Medical License 1994 - 2026
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Care360 EHR, MedPlus, A Quest Diagnostics Company, 2012, 2014
Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Symptom Burden in Patients Treated With Ocrelizumab for Multiple Sclerosis Start of enrollment: 2020 Oct 26
COMPLETED

Publications & Presentations

PubMed

1 citations
A multicenter cohort of transgender and gender diverse people with multiple sclerosis.
Alexandra Balshi, Talia B Feldman, John P Dempsey, Ursela Baber, Tamara B Kaplan
Multiple Sclerosis. 2025-10-01
3 citations
A Real-World Prospective Multiple Sclerosis Pregnancy Registry in the United States: PREG-MS.
Maria K Houtchens, Maria Claudia Manieri, Tatenda Dawn Mahlanza, Jeta Pol-Patil, Eric C Klawiter
Neurology. Clinical Practice. 2025-04-01
Corrigendum: Switching to ublituximab from prior anti-CD20 monoclonal antibody therapy: a case report series.
Regina Berkovich, Jonathan Calkwood, Heidi Crayton, April Erwin, Simon Faissner
Frontiers in Immunology. 2025-01-01

Press Mentions

‘It Isn’t over for Us’: For Those with Weakened Immune Systems, COVID-19 Vaccines Don’t Mean the End of the PandemicJune 27th, 2021
Secondary Progressive MS: The BasicsNovember 7th, 2019
Cladribine Shows Sustained Benefit & Safety in Older Patients with MS | ACTRIMS 2026February 10th, 2026